H Konrad Muller-Hermelink

Author PubWeight™ 54.21^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.	N Engl J Med	2002	24.07
2	Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells.	N Engl J Med	2004	12.20
3	The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma.	Cancer Cell	2003	6.11
4	Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma.	J Exp Med	2003	6.06
5	Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project.	Blood	2004	2.13
6	Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival.	Blood	2007	1.60
7	Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions.	Blood	2005	1.19
8	Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survival.	Blood	2006	1.10
9	Non-Hodgkin lymphoma in Chile: a review of 207 consecutive adult cases by a panel of five expert hematopathologists.	Leuk Lymphoma	2012	0.76